Oracle Corporation

New York Stock Exchange
Back to all articles
Somewhat Bearish -35

Oracle Q4: The $638 Billion Question (Rating Downgrade)

📉 Analyst Mesut Dogan downgrades Oracle (ORCL) from Buy to Hold following Q4 FY26 results.

💰 Oracle guided for $70 billion in CapEx for FY27, surpassing the $67.66 billion consensus estimate.

⚠️ The guidance includes an additional $20B-$25B of prepayments that require revenue conversion.

🏗️ Key risk identified is the ability to turn massive capital spend into timely revenue.

🇺🇸 Analyst warns of potential U.S. datacenter delays affecting Oracle's RPO targets.

📉 Recommendation is to wait for a stock price recovery rather than buying the current dip.

Bullish Signals
  • The analyst explicitly states they can 'live with weak free cash flow' during the buildout phase, indicating that the immediate cash burn is not viewed as an existential threat.
  • The downgrade is driven by a specific concern about timing and execution rather than a fundamental rejection of Oracle's business model or long-term viability.
Risk Factors
  • Oracle's $70 billion CapEx guidance for FY27 significantly exceeds the $67.66 billion consensus, raising concerns about valuation and market reaction.
  • There is a specific risk that Oracle may fail to convert its prepayments into revenue on time, potentially leading to accounting adjustments or missed targets.
  • The analyst highlights increasing risks of broader datacenter delays in the U.S., which could directly delay Oracle's RPO conversion targets.
  • The analyst advises against buying the current dip, suggesting that waiting for a recovery to pre-Q4 levels is the prudent strategy.
Full Analysis
Analyst Mesut Dogan has downgraded Oracle Corporation (ORCL) stock to a 'Hold' rating following the company's Q4 FY26 earnings report. The primary catalyst for the downgrade is Oracle's guidance of $70 billion in capital expenditure (CapEx) for fiscal year 2027, which significantly exceeds the market consensus estimate of $67.66 billion. Additionally, the analyst notes that the guidance includes an extra $20 billion to $25 billion in prepayments. The core concern driving this negative sentiment is whether Oracle can successfully convert its massive capital spending into revenue on schedule. While the author acknowledges that weak free cash flow might be acceptable during a buildout phase, there is a distinct lack of confidence regarding the timing of shipments and the realization of revenue from these prepayments. The analyst specifically worries about potential delays in broader U.S. datacenter projects, which could negatively impact Oracle's Revenue Per Order (RPO) conversion targets. Consequently, Dogan advises investors to wait for shares to recover to pre-Q4 levels before considering a purchase, rather than buying into the current dip blindly. The analyst expresses a preference for avoiding the risk of missing out on a potential discount if the stock price rebounds, citing the uncertainty surrounding the execution of such a large-scale infrastructure plan as a significant headwind.